Skip to content

Phibro Animal Health

US · PAHC #2966 by market cap Listed 1970
33.29 -0.79 -2.32%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Earnings Flash (PAHC) Phibro Animal Health Corporation Posts Q1 Adjusted EPS $0.79 per Share, Vs. FactSet Est of $0.78
    MT Newswires · 2026/11/5
  • Rating change
    Morgan Stanley Maintains Phibro Animal Health(PAHC.US) With Hold Rating, Raises Target Price to $45
    Market Newswire · 2025/11/8
  • Earnings Flash (PAHC) Phibro Animal Health Corporation Reports Q1 Revenue $386.8M, Vs. FactSet Est of $382.4M
    MT Newswires · 2026/11/5
  • Rating change
    J.P. Morgan Maintains Phibro Animal Health(PAHC.US) With Buy Rating
    Market Newswire · 2026/6/12
  • Rating change
    J.P. Morgan Maintains Phibro Animal Health(PAHC.US) With Buy Rating, Announces Target Price $58
    Market Newswire · 2026/8/25
  • Rating change
    BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Raises Target Price to $32
    Market Newswire · 2026/1/30
  • Rating change
    BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Maintains Target Price $32
    Market Newswire · 2026/2/5
  • Rating change
    J.P. Morgan Maintains Phibro Animal Health(PAHC.US) With Buy Rating, Cuts Target Price to $55
    Market Newswire · 2026/9/2
  • Rating change
    Citi Maintains Phibro Animal Health(PAHC.US) With Hold Rating, Maintains Target Price $62
    Market Newswire · 2026/4/16
  • Rating change
    Analysts Have Conflicting Sentiments on These Healthcare Companies: Phibro Animal Health (PAHC), Universal Health (UHS) and CG Oncology, Inc. (CGON)
    TipRanks · 2026/7/28
  • Phibro Animal Health (PAHC.US) will release its financial report after hours on November 4.
    Market Newswire · 2026/10/30
  • Rating change
    J.P. Morgan Maintains Phibro Animal Health(PAHC.US) With Buy Rating, Raises Target Price to $58
    Market Newswire · 2026/2/9
  • Rating change
    J.P. Morgan Maintains Phibro Animal Health(PAHC.US) With Buy Rating, Raises Target Price to $50
    Market Newswire · 2025/11/7
  • J.P. Morgan Maintains Phibro Animal Health(PAHC.US) With Buy Rating, Maintains Target Price $55
    Market Newswire · 2026/10/16
  • Rating change
    BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Raises Target Price to $38
    Market Newswire · 2026/2/6
  • Rating change
    Citi Maintains Phibro Animal Health(PAHC.US) With Hold Rating, Maintains Target Price $44
    Market Newswire · 2026/5/14
  • Form 144 | Phibro Animal Health(PAHC.US) 10% Stockholder Proposes to Sell 12.36 Million in Common Stocks
    Market Newswire · 2026/9/17
  • Rating change
    Citi Maintains Phibro Animal Health(PAHC.US) With Hold Rating, Cuts Target Price to $44
    Market Newswire · 2026/5/14
  • Rating change
    Citi Initiates Phibro Animal Health(PAHC.US) With Hold Rating, Announces Target Price $62
    Market Newswire · 2026/4/15
  • Rating change
    BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating
    Market Newswire · 2026/7/28
  • Rating change
    BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Maintains Target Price $27
    Market Newswire · 2025/8/29
  • Rating change
    J.P. Morgan Reaffirms Their Buy Rating on Phibro Animal Health (PAHC)
    TipRanks · 2025/9/1
  • Rating change
    BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Raises Target Price to $27
    Market Newswire · 2025/8/29
  • Earnings Flash (PAHC) Phibro Animal Health Posts Fiscal Q4 Revenue $396.7M, Vs. FactSet Est of $381.2M
    MT Newswires · 2026/8/27

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Phibro Animal Health discussion 0 comments

Add a comment